← Leaderboards
Jeffrey B Arterburn
New Mexico State University Las Cruces
$15,359,887
Attributed
$18,762,767
Total exposure
16
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$66,639,693 · 18
By mechanism
P20$58,616,251 · 13
R01$5,843,874 · 2
S06$1,372,068 · 1
R21$807,500 · 2
Top collaborators
- Eric R Prossnitz18 shared
- Tudor I Oprea9 shared
- Kathryn Alyce Hanley2 shared
Most similar at New Mexico State University Las Cruces
Same institution · by research overlap
- Nikos Vasilakis$7,725,066
- Kathryn Alyce Hanley$6,790,009
- Shelley Lusetti$35,594,821
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsStructureBaseLeadMalignant NeoplasmsFundingMolecularIn VivoBiomedical ResearchNew MexicoProgramsMediatingBiologyReceptorIncidenceUnited States National Institutes Of HealthEstrogen ReceptorsEstrogensGrowthLeadershipPhysiologicalPhysiologyBiologicalAgonist
Grant awards (62)
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$1,024,823
R01 · FY2025 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$486,792
R01 · FY2024 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$502,165
R01 · FY2023 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$525,537
R01 · FY2022 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$320,000
R01 · FY2020 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$310,400
R01 · FY2019 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$320,000
R01 · FY2018 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$320,000
R01 · FY2017 · CA
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands$320,000
R01 · FY2016 · CA
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE)$3,612,343
P20 · FY2015 · GM · contact PI
Developmental Research Project Program$1,911,945
P20 · FY2015 · GM · contact PI
Administrative Core$934,400
P20 · FY2015 · GM · contact PI
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE)$3,710,905
P20 · FY2014 · GM · contact PI
Developmental Research Project Program$1,999,007
P20 · FY2014 · GM · contact PI
Administrative Core$934,400
P20 · FY2014 · GM · contact PI
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) [P20]$3,378,920
P20 · FY2013 · GM · contact PI
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) [P20]$3,501,471
P20 · FY2012 · GM · contact PI
Development of GPR30-Selective Ligands$300,749
R01 · FY2012 · CA
A new synergy for flavivirus therapy: RNAi enhancement and viral mutagens$213,000
R21 · FY2012 · AI
Development of GPR30-Selective Ligands$19,934
R01 · FY2012 · CA
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) [P20]$3,502,311
P20 · FY2011 · RR · contact PI
NM-INBRE ADMINISTRATIVE CORE$512,493
P20 · FY2011 · RR · contact PI
Development of GPR30-Selective Ligands$300,749
R01 · FY2011 · CA
A new synergy for flavivirus therapy: RNAi enhancement and viral mutagens$177,500
R21 · FY2011 · AI
Development of GPR30-Selective Ligands$52,552
R01 · FY2011 · CA
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) [P20]$3,537,688
P20 · FY2010 · RR · contact PI
NM-INBRE ADMINISTRATIVE CORE$517,670
P20 · FY2010 · RR · contact PI
Development of GPR30-Selective Ligands$310,051
R01 · FY2010 · CA
Development of GPR30-Selective Ligands$52,637
R01 · FY2010 · CA
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) [P20]$3,204,248
P20 · FY2009 · RR · contact PI
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) [P20]$587,303
P20 · FY2009 · RR · contact PI
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) [P20]$529,202
P20 · FY2009 · RR · contact PI
NM-INBRE ADMINISTRATIVE CORE$458,175
P20 · FY2009 · RR · contact PI
Development of GPR30-Selective Ligands$310,051
R01 · FY2009 · CA
Development of GPR30-Selective Ligands$44,883
R01 · FY2009 · CA
New Mexico IDeA Networks of Biomedical Research Excellence$3,153,764
P20 · FY2008 · RR · contact PI
NM-INBRE ADMINISTRATIVE CORE$462,844
P20 · FY2008 · RR · contact PI
Development of GPR30-Selective Ligands$322,551
R01 · FY2008 · CA
New Mexico IDeA Networks of Biomedical Research Excellence$3,244,149
P20 · FY2007 · RR · contact PI
NM-INBRE ADMINISTRATIVE CORE$771,004
P20 · FY2007 · RR · contact PI
Pyridyl Hydrazine Conjugates as Radiopharmaceuticals$304,781
S06 · FY2007 · GM · contact PI
New Mexico IDeA Networks of Biomedical Research Excelle*$3,314,978
P20 · FY2006 · RR · contact PI
NM-INBRE ADMINISTRATIVE CORE$689,182
P20 · FY2006 · RR · contact PI
Pyridyl Hydrazine Conjugates as Radiopharmaceuticals$141,552
S06 · FY2006 · GM · contact PI
New Mexico IDeA Networks of Biomedical Research Excelle*$3,381,991
P20 · FY2005 · RR
NM-INBRE ADMINISTRATIVE CORE$722,035
P20 · FY2005 · RR
Pyridyl Hydrazine Conjugates as Radiopharmaceuticals$137,531
S06 · FY2005 · GM
New Mexico IDeA Networks of Biomedical Research Excelle*$91,000
P20 · FY2005 · RR
New Mexico IDeA Networks of Biomedical Research Excelle*$3,442,376
P20 · FY2004 · RR
NMSU BRIN: ADMINISTRATIVE CORE$550,780
P20 · FY2004 · RR
CORE--NMSU BRIN FACILITIES$275,390
P20 · FY2004 · RR
Pyridyl Hydrazine Conjugates as Radiopharmaceuticals$133,627
S06 · FY2004 · GM
NEW MEXICO BIOMEDICAL RESEARCH INFRASTRUCTURE NETWORK$2,041,293
P20 · FY2003 · RR
Novel Antirivals for Hantavirus Pulmonary Syndrome$208,500
R21 · FY2003 · AI
NEW MEXICO BIOMEDICAL RESEARCH INFRASTRUCTURE NETWORK$1,786,433
P20 · FY2002 · RR
Novel Antirivals for Hantavirus Pulmonary Syndrome$208,500
R21 · FY2002 · AI
NEW METHODS FOR RADIOLABELING WITH Tc and Re$172,411
S06 · FY2002 · GM
NEW METHODS FOR RADIOLABELING WITH Tc and Re$172,411
S06 · FY2002 · GM
NEW MEXICO BIOMEDICAL RESEARCH INFRASTRUCTURE NETWORK$1,856,551
P20 · FY2001 · RR
NEW METHODS FOR RADIOLABELING WITH Tc and Re$172,411
S06 · FY2001 · GM
NEW METHODS FOR RADIOLABELING WITH Tc and Re$68,672
S06 · FY2001 · GM
NEW METHODS FOR RADIOLABELING WITH Tc and Re$68,672
S06 · FY2000 · GM